Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.
maltose tetrapalmitate
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
1994
Review
1994
Antiangiogenesis is an appealing therapeutic modality for the treatment of a number of clinically important diseases, including… Expand
1993
1993
Maltose tetrapalmitate (MTP), a non-toxic synthetic glycolipid analog of lipid A, has been shown to have antitumor activity in… Expand
1989
1989
The antitumor activity of either cortisone-heparin or cortisone-maltose tetrapalmitate combination or both was tested against two… Expand
1989
1989
Pathological studies were undertaken in three tumor-host models which were subjected to cortisone based treatments. The first… Expand
1988
1988
We divided randomly into 3 groups 47 patients with recurrent superficial transitional cell carcinoma of the bladder: group 1-15… Expand
1988
1988
Treatment of human colonic cancer in early stages when the process is still limited to the colonic wall is primarily surgery. We… Expand
1986
1986
Therapeutic effects of radiotherapy (R), chemotherapy, and maltose tetrapalmitate (MTP) immunotherapy alone and in combinations… Expand
1985
1985
Maltose tetrapalmitate (MTP), a synthetic nontoxic immunoadjuvant, the radiosensitizer misonidazole (MISO), and 60Co gamma… Expand
1984
1984
Chemoimmunotherapy in two animal models for urological cancers was studied. The models were Dunning R3327A prostatic carcinoma… Expand
1980
1980
The effectivenss of maltose tetrapalmitate (MTP) as an antitumour immune adjuvant was verified by its comparison with other known… Expand